CN103483243B - 一种磺酸酯吡啶盐生物显影材料及其制备方法 - Google Patents
一种磺酸酯吡啶盐生物显影材料及其制备方法 Download PDFInfo
- Publication number
- CN103483243B CN103483243B CN201310422583.2A CN201310422583A CN103483243B CN 103483243 B CN103483243 B CN 103483243B CN 201310422583 A CN201310422583 A CN 201310422583A CN 103483243 B CN103483243 B CN 103483243B
- Authority
- CN
- China
- Prior art keywords
- sulphonate
- pyridinium salt
- target product
- developing material
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000463 material Substances 0.000 title claims abstract description 18
- -1 sulphonate pyridinium salt Chemical class 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 230000000694 effects Effects 0.000 abstract description 9
- 208000019065 cervical carcinoma Diseases 0.000 abstract description 5
- 230000005284 excitation Effects 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 238000011534 incubation Methods 0.000 abstract description 3
- 230000005779 cell damage Effects 0.000 abstract description 2
- 208000037887 cell injury Diseases 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000523 sample Substances 0.000 description 5
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical compound CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- 239000012472 biological sample Substances 0.000 description 3
- 230000008045 co-localization Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229960004132 diethyl ether Drugs 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 101100391174 Dictyostelium discoideum forC gene Proteins 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- BRXCDHOLJPJLLT-UHFFFAOYSA-N butane-2-sulfonic acid Chemical compound CCC(C)S(O)(=O)=O BRXCDHOLJPJLLT-UHFFFAOYSA-N 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000012771 intravital microscopy Methods 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 230000000886 photobiology Effects 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000048 toxicity data Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
Abstract
本发明公开了一种磺酸酯吡啶盐生物显影材料及其制备方法,其中磺酸酯吡啶盐生物显影材料的结构式为:
Description
一、技术领域
本发明涉及一种生物显影材料及其制备方法,具体地说是一种磺酸酯吡啶盐生物显影材料及其制备方法,具有人体宫颈癌细胞显影功能。
二、背景技术
继生物光学显微镜、普适性生物荧光显微镜、共聚焦荧光显微镜之后,双光子荧光显微镜已经成为新一代的细胞和组织的微观成像工具。与传统的单光子荧光共聚焦显微镜相比,双光子荧光显微镜在成像细胞和组织方面显示出了许多显著的优势:红外激发、生物样品穿透深、自发荧光低、生物样品的光损伤小、明显延长活细胞和组织的观测时间等。特别是双光子荧光显微镜在对活性生物样品的观测上体现出独特的优势,这使得生物科学家们得以在活的细胞和组织中观察和研究生命过程。荧光显微探测技术与荧光探针是相互依存互相促进的,新的荧光技术需要新的探针,新的探针将使探测技术更加完善。双光子荧光探针的研究是随着双光子荧光显微镜的出现而逐渐发展起来的,但其研究工作的相对滞后则限制了它们在双光子荧光显微镜上的广泛应用。因此,发展具有大吸收截面、高荧光量子产率的双光子荧光探针具有非常重要的科学意义和应用价值。
近年来,设计合成双光子荧光生物显影材料备受关注。众所周知,具有双光子活性的化合物,大多是具有大共轭体系的有机物,水溶性较差,不利于在生物体内的应用。因此,设计合成具有良好生物相容性的双光子荧光材料,是制备用于生物体双光子荧光探针的关键。
发明人对本申请的主题进行了如下的文献检索:
1、www.google.com网检索结果:(2013/9/2)
2、中国期刊网检索结果:
检索方式一:
篇名-磺酸酯吡啶盐生物显影材料无相关文献。
篇名-水溶性吡啶盐双光子荧光材料无相关文献。
检索方式二:
全文-磺酸酯吡啶盐生物显影材料无相关文献。
全文-水溶性吡啶盐双光子荧光材料无相关文献。
三、发明内容
本发明旨在提供一种磺酸酯吡啶盐生物显影材料及其制备方法,所要解决的技术问题是通过分子设计合成具有双光子活性的化合物,同时使其具有较好的水溶性和低毒性,以利于在生物体内的应用。
本发明以具有较好的双光子活性的吡啶盐为母体,引入磺酸酯提高化合物的水溶性,并在端基修饰柔性醚氧链基团,进一步增加水溶性和脂溶性,简洁高效地制备了具有π共轭体系的吡啶盐类衍生物(目标产物TM)。本发明目标产物TM在960nm左右具有较大的双光子吸收截面,能够完全溶于水安全地用于活体细胞显微成像,使之在生命科学研究领域具有明显的应用前景。
本发明磺酸酯吡啶盐生物显影材料的结构式为:
本发明磺酸酯吡啶盐生物显影材料的制备方法按以下步骤操作:
1)中间体M的合成
将4.10g(0.03mol)1,3-丙磺酸内酯和2.80g(0.03mol)γ-甲基吡啶溶于50mL丙酮中,加热回流反应4h,反应结束后冷却至室温,抽滤并用乙醚洗涤,真空干燥,得中间体M—甲基丙磺酸酯吡啶盐,为白色固体。
2)目标产物TM的合成
将3.25g(0.01mol)4-(双(2-(2-甲氧基乙氧基)乙基)氨基)苯甲醛和2.31g(0.01mol)中间体M溶解于50mL乙腈溶液中,然后加入催化剂六氢吡啶0.1mL,加热回流反应14h,反应结束后冷却至室温,旋蒸除去溶剂得到红色油状物,柱色谱分离(展开剂按体积比二氯甲烷:甲醇=2:1)后得到目标产物TM,为红色油状物。
本发明磺酸酯吡啶盐生物显影材料(简称目标产物TM)的合成路线如下:
与已有技术相比,本发明的有益效果体现在:
1、本发明目标产物TM与文献报道相比水溶性好,可以完全溶于水,并且在水中仍具有双光子活性(图1)。
2、本发明目标产物TM具有较低的毒性,20μMTM着色人体宫颈癌细胞(HepG2)在24h的孵化期间活性保持在95%左右(图2)。
3、本发明目标产物TM具有很好的细胞穿透性(图3),且这种低能激发高能发射的光(960nm激发,600nm发射)具有对细胞损伤小的特点。
4、本发明目标产物TM稳定性好,所用的吡啶盐和磺酸酯等原料易得,成本低,合成简洁,产率高,是一种有实用价值的双光子荧光材料。
四、附图说明
图1是本发明目标产物TM水溶液的双光子荧光光谱,在960nm激光作为激发波长,得到浓度为10-3mol/LTM水溶液的双光子荧光光谱。
图2是MTT测试细胞毒性结果。通过MTT测试,使用人体宫颈癌细胞(HepG2)测定了TM的细胞毒性。结果表明活细胞被TM着色,且24h的孵化期、TM浓度范围为10μM-80μM,HepG2活性保持在90%以上,说明TM具有较低的细胞毒性。
图3是本发明目标产物TM单双光子荧光显影结果。其中(a)单光子作用图(470nm激发),(b)双光子作用图(960nm激发),(c)干扰对比图(DIC),(d)单双光子作用叠加图,(e)单双光子高共区域化散点图,(f)单双光子低共区域化散点图。由显影结果图3(f)可见,本发明目标产物TM可以显影人体宫颈癌细胞的溶酶体;由图3(e)和图3(f)单双光子高、低共区域化散点图的比较结果可知,双光子荧光显影具有更强的穿透性。
五、具体实施方式
1、中间体M的合成
称取4.10g(0.03mol)1,3-丙磺酸内酯和2.80g(0.03mol)γ-甲基吡啶,溶于50mL丙酮中,加热回流反应4h,反应结束后冷却至室温,抽滤并用乙醚洗涤,真空干燥,得中间体M—对甲基丙磺酸酯吡啶盐6.30g,为白色固体,产率91%。
lHNMR(DMSO-d6,400MHz),d(ppm):7.98(d,2H),7.05(d,2H),3.68(t,2H),2.83(t,2Hz),1.68(s,3H),1.25(m,2H).
2、目标产物TM的合成
将3.25g(0.01mol)4-(双(2-(2-甲氧基乙氧基)乙基)氨基)苯甲醛和2.31g(0.01mol)中间体M溶解于50mL乙腈溶液中,加入六氢吡啶0.1mL作为催化剂,加热至回流反应14h,反应结束后冷却至室温,旋蒸除去溶剂,柱色谱分离(展开剂按体积比为二氯甲烷:甲醇=2:1)后得到目标产物TM4.1g,为红色油状物,产率75%。
FT-IR(KBr,cm-1):2923(w),1641(w),1585(s),1524(m),1470(w),1399(w),1174(s),1120(m),1056(m),943(w),831(w),618(w),530(w).1H-NMR(400MHz,CD3COCD3):9.58(d,1H),8.94(d,2H),8.10(d,2H),7.63(d,2H),7.12(d,1H),6.85-6.83(q,2H),4.87-4.85(q,2H),3.59-3.58(t,4H),3.49-3.48(t,4H),3.29(s,6H),3.15-3.12(t,4H),1.89-1.86(q,4H),1.29(s,4H).13C-NMR(100MHz,DMSO-d6):153.8,149.8,143.6,141.7,130.3,122.4,117.1,115.5,111.5,71.3,69.7,67.8,50.1,40.1,27.4.MALDI-TOF:m/z,cal:522.24,found:523.37(M++H).Anal.Calc.forC26H38N2O7S:C,59.75;H,7.33;N,5.36.Found:C,59.78;H,7.35;N,5.33.
Claims (1)
1.一种磺酸酯吡啶盐生物显影材料,其特征在于其结构式为:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310422583.2A CN103483243B (zh) | 2013-09-17 | 2013-09-17 | 一种磺酸酯吡啶盐生物显影材料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310422583.2A CN103483243B (zh) | 2013-09-17 | 2013-09-17 | 一种磺酸酯吡啶盐生物显影材料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103483243A CN103483243A (zh) | 2014-01-01 |
CN103483243B true CN103483243B (zh) | 2015-11-11 |
Family
ID=49823895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310422583.2A Active CN103483243B (zh) | 2013-09-17 | 2013-09-17 | 一种磺酸酯吡啶盐生物显影材料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103483243B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106008486B (zh) * | 2016-05-31 | 2018-05-18 | 安徽大学 | 一种靶向细胞核仁的噻吩基六氟磷酸吡啶盐生物荧光探针及其合成方法 |
CN106496102B (zh) * | 2016-10-31 | 2019-02-05 | 安徽大学 | 一种线粒体双光子荧光粘度探针及其制备方法 |
CN107987014B (zh) * | 2017-12-13 | 2021-02-09 | 安徽大学 | 一种吡啶磺酸内盐化合物及其制备方法和用途 |
CN112961103B (zh) * | 2021-02-09 | 2021-07-30 | 广东海洋大学 | 一种含氮芥的三联吡啶配体及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050259249A1 (en) * | 2004-01-27 | 2005-11-24 | Dombeck Daniel A | Nonlinear optical detection of fast cellular electrical activity |
CN102942559A (zh) * | 2012-10-29 | 2013-02-27 | 安徽大学 | 一种柔性醚氧链嘧啶衍生物、其制备方法及其用途 |
-
2013
- 2013-09-17 CN CN201310422583.2A patent/CN103483243B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050259249A1 (en) * | 2004-01-27 | 2005-11-24 | Dombeck Daniel A | Nonlinear optical detection of fast cellular electrical activity |
CN102942559A (zh) * | 2012-10-29 | 2013-02-27 | 安徽大学 | 一种柔性醚氧链嘧啶衍生物、其制备方法及其用途 |
Non-Patent Citations (3)
Title |
---|
Effect of Substituents on Aggregation Behaviors of Stilbazole and S tilbazolium Derivatives;YANG, Wen-Sheng,等;《CHINESE JOURNAL OF CHEMISTRY》;20100826;第19卷(第7期);652-656 * |
Synthesis and properties of substituted (p-aminostyryl)-1-(3-sulfooxypropyl)pyridinium inner salts as a new class of two-photon pumped lasing dyes;Qingdong Zheng,等;《J. Mater. Chem.》;20030902;第13卷(第10期);2500页方案2化合物6c,2500页方案2,2504页左栏第2-4段 * |
双光子荧光探针;黄池宝,等;《化学进展》;20121231;第22卷(第12期);2409-2410 * |
Also Published As
Publication number | Publication date |
---|---|
CN103483243A (zh) | 2014-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103483243B (zh) | 一种磺酸酯吡啶盐生物显影材料及其制备方法 | |
CN103614135B (zh) | 一种双光子荧光探针及其制备方法和用途 | |
Wang et al. | A novel colorimetric and near-infrared fluorescent probe for hydrogen peroxide imaging in vitro and in vivo | |
CN103436251A (zh) | 一种比率计型双光子镉离子荧光探针及其合成方法 | |
CN113402514B (zh) | 一种有机染料化合物及其制备方法和应用 | |
JP5997288B2 (ja) | ナフタレンを基本骨格とする二光子蛍光プローブ、その製造方法及びその利用方法 | |
CN103467455A (zh) | 一种具有活体组织显影功能的锌配合物双光子吸收材料及其制备方法 | |
CN105062467A (zh) | 一种转子型的双红线粒体荧光探针及其应用 | |
CN105295897B (zh) | 一种dna双光子比率荧光粘度探针及其制备方法 | |
CN105121446A (zh) | 亚锡荧光探头 | |
CN102614198A (zh) | (4-取代苯甲酰)氟苯水杨酰胺类化合物在制备抗肺癌药物中的应用 | |
CN103710021B (zh) | 以硝基苯并咪唑为rna识别基团的荧光染料、其制备方法及应用 | |
CN103709203B (zh) | 一类双核钌配合物及其制备方法和作为活细胞荧光染料的应用 | |
CN104327537A (zh) | 一种具有生物膜透性潜能的氧杂蒽类荧光染料及其制备方法 | |
CN106867513A (zh) | 一种细胞膜定位锌离子荧光探针及其制备方法和应用 | |
CN110041248B (zh) | 3,5-双(2,4-二甲氧基苯基)吡啶二元环、其制备方法及应用 | |
CN102249939B (zh) | 脂水两亲性亚苄基环戊酮染料及其制备方法与在光动力治疗中的用途 | |
CN101962536B (zh) | 溶酶体靶向的荧光物质及其合成方法 | |
CN103725758B (zh) | 一种近红外生物荧光染料在活细胞成像中的应用 | |
CN109776379A (zh) | 一种可用于响应活细胞内和慢性伤口发展过程中pH变化的近红外荧光探针及其制备方法 | |
CN102634224B (zh) | 一类4位n取代的蒽吡啶酮荧光染料、其制备方法及应用 | |
CN104059378B (zh) | 一种六位取代的香豆素衍生物双光子荧光染料及其制备方法 | |
KR20130100620A (ko) | 생체 조직 내 일산화질소 활성 감지를 위한 이광자 형광 프로브 및 이의 제조 방법과 이를 이용한 생체 조직 내 일산화질소 활성의 영상화 방법 | |
CN104448897B (zh) | 末端官能化的以萘为母体的双光子荧光染料 | |
CN101519387B (zh) | 一种吩噻嗪衍生物双光子生物显影材料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171121 Address after: Two road 523000 in Guangdong province Dongguan City Songshan Lake high tech Industrial Development Zone headquarters No. 2 District 1 Building 1 room 1001 Patentee after: Guangdong Branch Road heat source technology Co. Ltd. Address before: 230601 Hefei economic and Technological Development Zone, Anhui, Kowloon Road, No. 111 Patentee before: Anhui University |
|
TR01 | Transfer of patent right |